Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...
EnVista, an Indianapolis-based software, consulting, managed services and automation solutions firm whose customer base includes distributors, on Monday announced the acquisition of systems integrator ...
ADP Automatic Data Processing, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback